OCT Device for Ear Infection
(OCTII Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this project is to see if optical coherence tomography (OCT), a new technology acting as an ultrasound for the ear, facilitates accurately diagnosing acute otitis media (AOM) and otitis media with effusion (OME) in children. Clinical diagnoses made using solely otoscopy will be compared to those made with the addition of OCT.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the OCT Device treatment for ear infections?
Is the OCT Device safe for use in humans?
Research on various OCT devices, including those used for ear conditions, suggests they are generally safe for human use. Studies have demonstrated the feasibility and safety of OCT systems in different applications, such as imaging the tympanic membrane and inner ear, without reporting significant safety concerns.14567
How is the OCT Device treatment for ear infections different from other treatments?
The OCT Device for ear infections is unique because it uses optical coherence tomography to non-invasively and quantitatively assess middle ear conditions, providing detailed images and identifying bacterial biofilms, unlike traditional methods that rely on subjective visual cues. This device is portable and includes a machine learning platform for accurate diagnosis, making it a novel tool for managing ear infections.14589
Research Team
Joseph Kerschner, MD
Principal Investigator
Medical College of Wisconsin
Eligibility Criteria
This trial is for children with a parent-reported ear infection or pain, or those referred for otitis media with effusion evaluation at specific clinics. Participants must speak English. Children with current ear tubes, craniofacial abnormalities, immunologic or syndromic conditions, or effusion present for less than 8 weeks are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Comparative Assessment
Comparative assessment of middle ear pathology using otoscopy and OCT in pediatric patients
Algorithm Development
Development of image processing and machine learning algorithms for automated identification of effusions and biofilms in OCT image data
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- OCT Device(s)
OCT Device(s) is already approved in United States, European Union for the following indications:
- Acute otitis media (AOM)
- Otitis media with effusion (OME)
- Middle ear effusions
- Bacterial biofilms in the middle ear cavity
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
University of Illinois at Urbana-Champaign
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator